Skip to content
value.today

Peerbridge Health, Inc.

🇺🇸 New York, New York, USABiotechnologyFounded 2012

Formerly Wireless Live Inc.

Total raised
$59 M
11 rounds on record
Latest round
$7 M
May 2025
First round on record
Dec 2014
Today
Private
No later event on record

Funding rounds

11 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Peerbridge Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2025$7 MNo. 11$2 to $10 million

Peerbridge Health, Inc.: Raise no. 11, May 2025

Investors in this round

25 investors had bought by the notice of Aug 15, 2025: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$250,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Darland · Executive Officer, Director
  • Dan Reuvers · Director
  • Mark Bakken · Director
  • Nicholas Jackson · Director
  • Patrick Horan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Darland, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 15, 2025. Read the notice at the SEC.

equitySEC
Jun 2024$14 MNo. 10$10 to $50 million

Peerbridge Health, Inc.: Raise no. 10, Jun 2024

Investors in this round

28 investors had bought by the notice of Jun 20, 2024: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $19 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$150,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Darland · Executive Officer, Director
  • Mark Bakken · Director
  • Nicholas Jackson · Director
  • Patrick Horan · Director
  • Tamanna Bembenek, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Darland, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 20, 2024. Read the notice at the SEC.

equitySEC
Feb 2023$5 MNo. 9$2 to $10 million

Peerbridge Health, Inc.: Raise no. 9, Feb 2023

Investors in this round

26 investors had bought by the notice of Feb 28, 2023: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: CONVERTIBLE NOTES
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$150,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Darland · Executive Officer
  • Greg Tracy · Director
  • Mark Bakken · Director
  • Nicholas Jackson · Director
  • Patrick Horan · Director
  • TAMANNA BEMBENEK, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Darland, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 28, 2023. Read the notice at the SEC.

equitySEC
Jan 2022$7 MNo. 8$2 to $10 million

Peerbridge Health, Inc.: Raise no. 8, Jan 2022

Investors in this round

24 investors had bought by the notice of Feb 14, 2022: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $11 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, other: CONVERTIBLE NOTES
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$5,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adrian Gilmore · Executive Officer, Director
  • Michael Fawkes · Executive Officer, Director
  • Angelo Acquista · Director
  • Richard Mulry · Director
  • Todd Asmuth · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offering consists of $5,000,000 in cash with the remainder in exchange of convertible notes.”

Signed by Adrian Gilmore, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 14, 2022. Read the notice at the SEC.

optionsSEC
Apr 2021$3 MNo. 7$2 to $10 million

Peerbridge Health, Inc.: Raise no. 7, Apr 2021

Investors in this round

4 investors had bought by the notice of May 5, 2021: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, other: convertible notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adrian Gilmore · Executive Officer, Director
  • Michael Fawkes · Executive Officer
  • Angelo Acquista · Director
  • Richard Mulry · Director
  • Todd Asmuth · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adrian Gilmore, Ceo. Source: SEC Form D, newest notice filed May 5, 2021. Read the notice at the SEC.

optionsSEC
Aug 2020$3 MNo. 6$2 to $10 million

Peerbridge Health, Inc.: Raise no. 6, Aug 2020

Investors in this round

1 investor had bought by the notice of Aug 25, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adrian Gilmore · Executive Officer, Director
  • Michael Fawkes · Executive Officer, Director
  • Angelo Acquista · Director
  • Avi Kometz · Director
  • Richard Mulry · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adrian Gilmore, Ceo. Source: SEC Form D, newest notice filed Aug 25, 2020. Read the notice at the SEC.

equitySEC
Oct 2019$11 MNo. 5$10 to $50 million

Peerbridge Health, Inc.: Raise no. 5, Oct 2019

Investors in this round

10 investors had bought by the notice of Nov 5, 2019: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $20 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, other: CONVERTIBLE NOTES
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adrian Gilmore · Executive Officer, Director
  • Michael Fawkes · Executive Officer, Director
  • Angelo Acquista · Director
  • Avi Kometz · Director
  • Gregory Fontana · Director
  • Richard Mulry · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ATLANTIC-PACIFIC CAPITAL, INC. (CRD 38356) · Greenwich, ConnecticutSold in all US states, and outside the US

Signed by Adrian Gilmore, Ceo. Source: SEC Form D, newest notice filed Nov 5, 2019. Read the notice at the SEC.

optionsSEC
May 2018$1 MNo. 4Under $2 million

Peerbridge Health, Inc.: Raise no. 4, May 2018

Investors in this round

11 investors had bought by the notice of Jun 4, 2018: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, other: convertible notes
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur Bertolero · Executive Officer, Director
  • Michael Fawkes · Executive Officer, Director
  • Angelo Acquista · Director
  • Avi Kometz · Director
  • Gregory Fontana · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Atlantic Pacific Capital, Inc. (CRD 38356) · broker-dealer Atlantic Pacific Capital, Inc. (CRD 38356) · Greenwich, ConnecticutSold in all US states

Signed by Arthur Bertolero, Ceo. Source: SEC Form D, newest notice filed Jun 4, 2018. Read the notice at the SEC.

optionsSEC
Mar 2017$2 MNo. 3Under $2 million

Peerbridge Health, Inc.: Raise no. 3, Mar 2017

Investors in this round

11 investors had bought by the notice of Mar 23, 2017: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, other: Convertible Note
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur Bertolero · Executive Officer, Director
  • Michael Fawkes · Executive Officer, Director
  • Angelo Acquista · Director
  • Avi Kometz · Director
  • Gregory Fontana · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Arthur Bertolero, Ceo. Source: SEC Form D, newest notice filed Mar 23, 2017. Read the notice at the SEC.

optionsSEC
Mar 2016$1 MNo. 2Under $2 million

Peerbridge Health, Inc.: Raise no. 2, Mar 2016

Investors in this round

1 investor had bought by the notice of Mar 31, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $55 M offered; $54 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$3,300,000
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur Bertolero · Executive Officer, Director
  • Michael Fawkes · Executive Officer, Director
  • Angelo Acquista · Director
  • Avi Kometz · Director
  • Gregory Fontana · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ATLANTIC-PACIFIC CAPITAL, INC. (CRD 38356) · Greenwich, ConnecticutSold in all US states

Remarks in the notice

  • On fees: “ABOVE SALES COMMISSION ASSUMES SALE OF TOTAL OFFERING AMOUNT OF $55,000,000 AND IS SUBJECT TO CERTAIN CARVE-OUTS.”

Signed by Arthur Bertolero, President. Source: SEC Form D, newest notice filed Mar 31, 2016. Read the notice at the SEC.

equity, optionsSEC
Dec 2014$5 MNo. 1$2 to $10 million

Peerbridge Health, Inc.: Raise no. 1, Dec 2014

Investors in this round

7 investors had bought by the notice of Jan 7, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $9 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$450,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur Bertolero · Executive Officer, Director
  • Michael Fawkes · Executive Officer, Director
  • Angelo Aquista · Director
  • Avi Kometz · Director
  • Gregory Fontana · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Arthur Bertolero, President. Source: SEC Form D and 2 amendments, newest notice filed Jan 7, 2015. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Peerbridge Health, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2025).

    SEC Form D · Aug 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2025

That is all the official record says: Peerbridge Health, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Peerbridge Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 11 rounds above had up to 28 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Peerbridge Health, Inc.
NameRoleNamed in
Chris DarlandExecutive officerAug 2025
Adrian GilmoreExecutive officerFeb 2022
Michael FawkesExecutive officerFeb 2022
Arthur BertoleroExecutive officerJun 2018
Chris DarlandDirectorAug 2025
Dan ReuversDirectorAug 2025
Mark BakkenDirectorAug 2025
Nicholas JacksonDirectorAug 2025
Patrick HoranDirectorAug 2025
Tamanna Bembenek, Ph.D.DirectorJun 2024
Greg TracyDirectorFeb 2023
TAMANNA BEMBENEK, Ph.D.DirectorFeb 2023
Adrian GilmoreDirectorFeb 2022
Angelo AcquistaDirectorFeb 2022
Michael FawkesDirectorFeb 2022
Richard MulryDirectorFeb 2022
Todd AsmuthDirectorFeb 2022
Avi KometzDirectorAug 2020
Gregory FontanaDirectorNov 2019
Arthur BertoleroDirectorJun 2018
Angelo AquistaDirectorJan 2015
Ari KometzDirectorJan 2015